Polymorphisms in the RAD51 gene have been associated in previous studies with symptoms of heart failure and the appearance of a new primary tumor in patients with breast cancer treated with trastuzumab and RT [6], suggesting an important gene for RTX; however, such polymorphisms were not detected in the population studied. The gene discussed is RAD51; the disease is breast carcinoma.